Irwin Naturals Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Irwin Naturals şirketinin toplam hissedar öz sermayesi $13.9M ve toplam borcu $37.4M olup, bu da borç-öz sermaye oranını 269.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $70.9M ve $57.0M dir.

Anahtar bilgiler

269.2%

Borç/özkaynak oranı

US$37.38m

Borç

Faiz karşılama oranı	n/a
Nakit	US$5.48m
Eşitlik	US$13.88m
Toplam yükümlülükler	US$56.97m
Toplam varlıklar	US$70.86m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Insufficient Growth At Irwin Naturals Inc. (CSE:IWIN) Hampers Share Price

Dec 13

There Are Reasons To Feel Uneasy About Irwin Naturals' (CSE:IWIN) Returns On Capital

Oct 18

Irwin Naturals (CSE:IWIN) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Dec 01

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: IWIN 'nin kısa vadeli varlıkları ( $37.9M ) kısa vadeli yükümlülüklerini ( $48.4M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: IWIN şirketinin kısa vadeli varlıkları ( $37.9M ) uzun vadeli yükümlülüklerini ( $8.6M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: IWIN 'nin net borç/öz sermaye oranı ( 229.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: IWIN şirketinin borç/öz sermaye oranının son 5 yılda azalıp azalmadığını belirlemek için yeterli veri yok.

Borç Kapsamı: IWIN 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: IWIN şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.

Irwin Naturals Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

New major risk - Revenue and earnings growth

No independent directors

Irwin Naturals, Inc. Announces Directors Changes

Third quarter 2023 earnings released: US$0.56 loss per share (vs US$0.49 loss in 3Q 2022)

New minor risk - Share price stability

Irwin Naturals Announces Goodwill Impairment for the Second Quarter Ended June 30, 2023

Second quarter 2023 earnings released: US$1.57 loss per share (vs US$0.032 profit in 2Q 2022)

Irwin Naturals, Inc. Reports Impairment Charges for the First Quarter Ended March 31, 2023

First quarter 2023 earnings released: US$2.27 loss per share (vs US$1.12 profit in 1Q 2022)

Less than half of directors are independent

Irwin Naturals, Inc. Announces Election of Sheri Orlowitz as A New Director of the Company as of May 12, 2023

Irwin Naturals Inc. (CNSX:IWIN) completed the acquisition of Serenity Health.

Irwin Naturals Inc. (CNSX:IWIN) completed the acquisition of Serenity Health.

Irwin Naturals Inc. (CNSX:IWIN) signed letter of intent to acquire Braxia Scientific Corp. (CNSX:BRAX) for $30 million.

Insufficient Growth At Irwin Naturals Inc. (CSE:IWIN) Hampers Share Price

Investor sentiment improved over the past week

Third quarter 2022 earnings released: US$0.45 loss per share (vs US$1.22 loss in 3Q 2021)

Irwin Naturals Inc. (CNSX:IWIN) agreed to acquire Serenity Health.

High number of new and inexperienced directors

Irwin Naturals Inc. (CNSX:IWIN) signed binding, arms length agreement to acquire Assets of Tri-Cities Infusion & Wellness Clinic, PLLC.

Irwin Naturals Announces CFO Board Changes

Investor sentiment improved over the past week

There Are Reasons To Feel Uneasy About Irwin Naturals' (CSE:IWIN) Returns On Capital

Irwin Naturals Inc. (CNSX:IWIN) entered into an agreement to acquire Keta Media, LLC.

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: US$0.032 (vs US$2.83 in 2Q 2021)

Irwin Naturals Inc. (CNSX:IWIN) acquired Assets from Hobie Fuerstman DO PLC.

Irwin Naturals Inc. (CNSX:IWIN) completed the acquisition of Two ketamine clinics in Georgia from Invictus Clinic, LLC.

Irwin Naturals Inc. (CNSX:IWIN) completed the acquisition of Assets of New England Ketamine PLLC.

Irwin Naturals Inc. (CNSX:IWIN) entered into a definitive agreement to acquire Invictus Clinic, LLC.

Irwin Naturals Inc. (CNSX:IWIN) entered into a binding agreement to acquire Assets from Hobie Fuerstman D O PLC.

First quarter 2022 earnings released: EPS: US$1.12 (vs US$3.72 in 1Q 2021)

Irwin Naturals Inc. (CNSX:IWIN) completed the acquisition of KHC Capital Group, LLC.

Irwin Naturals Inc. (CNSX:IWIN) entered into a binding agreement to acquire Assets of New England Ketamine PLLC.

Irwin Naturals Inc. to Report Q4, 2021 Results on May 03, 2022

Full year 2021 earnings released

No independent directors

Irwin Naturals Inc. (CNSX:IWIN) entered into an acquisition agreement to acquire KHC Capital Group, LLC.

Irwin Naturals (CSE:IWIN) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

No independent directors

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin